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Background: Glycation of serum albumin and its consequence products were considered as an important factor in
drug distribution and diabetic complications, therefore finding the glycation inhibitors and their inhibitory mechanisms
became a valuable field of study. In this work, bovine serum albumin (BSA) became a subject as a model protein for
analyzing the inhibitory mechanism of flavonoids, known as natural BSA glycation inhibitors in the early stage of
glycation.
Methods: Firstly, for theoretical study, the three-dimensional model of BSA structure was generated by homology
modeling and refined through molecular dynamic simulation. Secondly, several validation methods (statistical
assessment methods and also neural network methods) by simultaneous docking study were employed for insurance
about accuracy of our simulation. Then docking studies were performed for visualizing the relation between flavonoids’
binding sites and BSA glycation sites besides, the correlation analyzes between calculated binding energy and reported
experimental inhibitory IC50 values of the flavonoids set, was considered to explore their molecular inhibitory
mechanism.
Results: The quality assessment methods and simultaneous docking studies on interaction of quercetin (as the
most studied flavonoids) with BSA and Human serum albumin (HAS), confirm the accuracy of simulation and the
second stage of docking results which were in close agreement with experimental observations, suggest that the
potential residues in flavonoids binding sites (which were place neighbor of tryptophan 212 within 5Ǻ) cannot be
considered as one of glycation sites.
Conclusions: Based on the results, flavonoids don’t participate in inhibitory interference mechanism, and also, the
differentiation between complexes of flavonoids with BSA and HSA could destroy the speculation of using them
as an exchangeable model protein in study of serum albumin and flavonoids interactions.
Keywords: Homology modeling, Molecular dynamics simulation, Correlation analyzes, Glycation sites, Flavonoids, BSABackground
Diabetes is considered as one of the main threat to
human health, according to WHO report, it is predicted
that diabetes will exceed to 300 million in the years of
2025. Diabetes has a devastating effect on almost every
organ in body. The hyperglycemia in diabetic conditions
causes non-enzymatic glycation of proteins [1]. This re-
action initiates the formation of reversible Schiff base* Correspondence: amanlou@tums.ac.ir
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unless otherwise stated.between glucose and ε-amino group of lysine residues in
proteins which by consequent intermolecular rear-
rangements leading to a formation of ketamine adduct.
Then, the potent precursors of protein cross-linkers
such as glucosone, 5-hydroxymethyl-2-furaldehyde, and 3-
deoxyglucosone are formed due to the initial reaction.
Next, those intermediates are oxidized, and cross linked,
and fluorescent heterogeneous group of protein-bound
moieties (called advanced glycated end products or AGEs)
are detected in the last stage of glycation [2,3]. With body
of evidence, formation and accumulation of advanced
glycation products can be considered as a major factortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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disease, and normal aging process. Therefore, the consid-
erable efforts have been made to propose and discover
inhibitors of glycation for therapeutic application in
treatment of diseases that advanced glycation end product
could be responsible for their pathogenesis [4].
Serum albumin is the most abundant protein in body
which has a tremendous interest for binding to various
natural or synthetic small-molecules such as glucose and
related compounds. In diabetic condition, serum albumin
undergoes glycation [5]. This character, continually expose
serum albumin to altering factors which can participate in
serum albumin modifications and biological compound
formation that can be considered as a causative agent for
some diseases [6]. Among the wide variety of interaction,
the none-enzymatic interaction of serum albumin with
glucose is one of the most important underlying modifica-
tion factors, which are in associated with various alter-
ations of albumin’s structure and functions [7,8].
Among the glycation inhibitors’ which were examined
on bovine serum albumin (BSA) as a model protein, spe-
cific considerations were given to dietary natural products
such as several phenolic compounds [9,10]. Researches on
a limited number of flavonoids compounds indicated their
ability to prevention both stage of glycation reaction [7].
In the late stage, the inhibition mechanisms of flavonoids
are that, they may act as a both metal chelator and radical
scavenger [11,12]. However, the inhibitory mechanism of
flavonoids in the early stage completely remains unclear
[7]. For some anti-glycation agent such as α-lipoate or
non-steroidal anti-inflammatory drugs such as diclofenac
and aspirin, hydrophobic hindrance or binding near the
glycation site was considered as possible mechanism of
anti-glycation activity [9,13]. Although we have no evi-
dence that flavonoids react with the glycation site [7], in
the present study, the attentions are drawn to binding
behavior of flavonoids to clarifying the inhibition mech-
anism of them for the early stage of glycation.
Since, docking simulation results can be used to under-
standing the molecular interaction and analyze biological
presses, rapidly and efficiently [2], in the present study, we
explored the series of flavonoids’ binding behavior with
BSA through docking studies.
However, in the case of BSA which was considered
here as a model protein (such as studies mentioned
above by Morimitsu, Y., et al. and Matsuda, H., et al.
[3,12]). When this study was started nobody has suc-
ceeded in obtaining crystals of intact BSA [14]. However,
simultaneous with our study the importance of this pro-
tein draws the other researchers’ attention to solving the
tertiary structure of BSA. However, the new crystals also
haven’t been at high resolution (<2 Å resolution limit)
[15], which can be satisfactory resolution for using in
docking simulation. In this study, simulation, homologymodeling was employed. While, it is generally recognized
that homology modeling of proteins could be considered
as accurate methods for 3D structure prediction while a
model and related template sharing high sequence identity
[16,17].
In present work, the model was refined with energy
minimization and molecular dynamic simulation. Then,
different assessment tools were adapted for checking the
proper folding of constructed BSA 3D structure.
Consequently, by docking methods the validity of the
model protein was examined and for getting better
insight into the flavonoids’ inhibitory mechanism. Firstly,
the predicted binding affinity and reported IC50 [12] was
subjected to correlation analyzes and secondly, the flavo-
noids binding location was studied for tracing the relation
among participated amino acids in the flavonoids’ binding
site with ones proposed as the glycation site of BSA [18].
In addition, according to docking results, the compari-
son is made between obtained 3D structure of BSA and
crystallographic structure of HSA for understanding their
specificity in flavonoids binding location and the verifica-
tion of using BSA and HSA as an exchangeable mode pro-
tein for the same case of investigation.
Methods
Amino acid sequence alignment and homology modeling
of bovine serum albumin
In the first step, Amino acid sequence of BSA (UniProt
ID: P02769) was retrieved from Swiss-Prot (http://www.
uniprot.org/uniprot). And then, Blastp matrix blosum62
against PDB database was used to find out the best hom-
ologous structure with a known 3D structure, for applying
as a template in homology modeling. Finally, among the
HSA structures, the structure with a highest resolution at
1.9 Å [19] that belong to HSA (PDB ID: 1N5U) was
adopted as the final target.
Sequence alignment was generated using 2d alignment
function of MODELLER 9v8 program (www.salilab.org/
modeller). Align 2d is based on a dynamic programming
algorithm, considering the template structural informa-
tion for constructing an alignment, this advantages is
more significant as the similarity between the sequences
decrease and the number of gaps increase [20]. After
alignment, the 3D structure of fifty models were calcu-
lated completely automatically with MODELLER 9v8 [21].
Refinement of homology model by minimization and MD
simulation
Molecular dynamic simulation were carried out using
the parallel version of GROMACS 4.5.3 [22] In the
AMBER99SB force field [23] to monitor stability and
conformation of the selected model. The starting coordi-
nates were taken from the best model that was retrieved
from MODELLER and for prediction of non-standard
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Among the whole residues that may be adapted standard
ionization state, lysine 219 was deprotonated and six
histidine residues (histidine 16, histidine 37, histidine
143, histidine 239, histidine 335, and histidine 332) were
completely protonated.
After assigning charge state, the protein was put into a
suitable sized simulation cubic box and immersed in
41760 simple point charges (SPC) water model. Then,
appropriate number of Na+ ions were added to neutralize
the charge of the system. The first energy minimization,
which targeted water molecules and ions alone while con-
figuration of protein was kept, fixed, followed by 20 ps
MD simulation which again, the protein was kept fixed
and the water molecules and ions were allowed to evolve.
The second minimization step began with 1000 steepest
descent and conjugate gradient of 9000 steps afterward.
For equilibrating further the system v-rescale thermostat
[25] was applied by using coupling constant (τt) of 0.1 ps
to keep the system at the constant temperature in 100 ps
at 100 K and 200 K respectively. While the pressure of the
system maintained at 1 atm by using the Berendsen weak
coupling algorithm [26] with coupling constant (τp) of
0.5 ps. For obtaining the stable system at 300 K and 1 atm,
the same aforementioned parameters were determined for
heating the system.
In this simulation, the non-bonded interactions were
calculated by applying a 14 Å cut off and periodic
boundary conditions were also applied in all directions.
The Electrostatic interactions were calculated using the
Particle Mesh Ewald (PME) [27]. During simulation, the
frame was stored at every 1.000 ps.
Subsequently, all the analysis was performed by taking
advantage of Gromacs tools and the structure which was
retrieved after system stabilization was subject to evalu-
ate the protein geometry.
Assessment of the homology model
To verify the quality of the model after molecular dynamic
refinement, using different tools, which include: PRoQ, as
a neural network based predictor [28], verify 3D, which
analyzes the compatibility of an atomic model (3D) with
its own amino acid sequence (1D) [29], PROSA program,
which evaluate the energy of using a distance based pair
potential [30] as well PROCHECK for checking the de-
tailed stereochemical properties [31].
Docking analysis
Autodock 4.0 [32] was used for docking studies and for
adding charges and active torsions to the ligands and as-
sign Kollman charges to protein AutoDockTools (ADT)
was employed. The rectangular lattice (100 × 100 × 100)
with points separated by 0.375 Ǻ was built by AutoGrid
that was superposed on subdomin IIA of serum albumin(proposed as a primarily binding site of flavonoids) [33].
The Lamarckian genetic algorithm (LGA) was used with
100 runs for docking simulation, while an initial popula-
tion size of 100, and the maximum number of 2500000
energy evaluations. All other parameters were set to default
values, and the results were ranked according to Autodock
scoring function and the final conformation of each struc-
ture was selected based on the highest dock score.
The chemical structures of interested flavonoids were
optimized at MM+ level of molecular mechanic methods
using HYPERCHEM software program (version 8.0.3
Hypercube, Inc) [34]. The geometry optimization was pre-
ceded by Polak-Ribiere algorithm to reach the 0.01 root
mean square gradient. Then all these refinement struc-
tures were subject to docking simulations.
MD simulation after docking
All MD simulations were performed using the Gromacs
4.5.3 program together with the 43a2 force field [35-37]
for each simulation to study the complex of BSA-quercetin,
while the topology of quercetin was generated by the
PRODRG 2.5 beta server [38].
Then, the protein was solvated by simple point charge
water molecule in the cubic box with minimal distance
of protein from its wall being 1.0 nm and the system
was neutralized by adding appropriate counter ions.
After performing energy minimization of the entire
system, it was equilibrated under NVT ensemble for
100 ps and the periodic boundary conditions were used
in tree-coordinate direction, whereas, position restrains were
placed on ligand using force restraint of 1000 kcal/mol.
NVT equilibration is followed by isothermal–isobaric
(NPT) which was performed for 100 ps. The pressure
of the system was regulated by Berendsen barostat with
a relaxation time (τp) of 2.0 ps. The position restraints
and simulation parameter which was applied in the
NPT ensemble was the same as the ones which have
been used during NPT equilibration. After convergence
had been reached, the protein-ligand and water-ions
groups were coupled in separate temperature baths, and
v-rescale thermostat was used to keep the temperature
constant at 300 k during the 2 ns simulation. Lennard-
Jones interactions were calculated within a cut-off distance
of 1.0 nm, and electrostatic interactions were treated with
the particle mesh Ewald’s method. Ultimately, from 2 ns
MD simulation, the structure with low RMSD value was
selected for analyzing the local conformational changes of
BSA- quercetin complex.
Computational resources
The computational studies were performed on computer
cluster 4 HP Prolient ML370-G5 Tower servers equipped
with 2 Quad Core Intel Xeon processors E5355, 2.66 GHz
and 4GB of RAM on a Linux platform.
Figure 1 Analysis of DOPE score profile (obtained from Modeller). The Blue line indicates, energy profile of HSA (PDB ID: 1N5U) which used
as a model and the red line indicates energy profile of target, which constructed by Modeller.
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Sequence alignment and modeling building
Based on the highest similarity and the lowest D-value,
human serum albumin (HSA) can be considered the best
homologues structure for BSA. The Sequence alignment
of BSA (UniProt ID: P02769) and HSA (UniProt ID:
P02768) which was generated by ClustalX program shows
76% identity between them [39]. The precursor proteins
of BSA and HSA have 603 and 607 amino acid in length,
respectively. Though all the crystallographic structures of
HSA which were reported, only consist of 583 aminoFigure 2 Analysis of a molecular dynamics simulation trajectory during
deviation (RMSD) plot of the model, during 5ns simulation. (B) The variation oacids. This can be referred to the fact that during a se-
cretion and maturation process of serum albumins, the
25 N-terminal amino acids were cleaved [40]. There-
fore, the 25 N –terminal amino acids, which are placed
out of the chain, were separated from the HSA amino
acids sequence and the rest of them used as a target for
homology modeling.
After alignment, the 3D structure of fifty models was
calculated completely automatically with modeler 9v8.
In this process, the population of the constructed model
was increased for improving the DOPE energy assessment5ns generated by Gromacs. (A) The backbone root mean square
f potential around constant value. (C) The fluctuation of total energy.
Figure 3 The Verify-3D analysis is shown for all residues. The blue line belongs to molecular structure after MD, and red one belongs to
model that constructed by the Modeller. The refinement model after MD was validated by positive scores of Verify-3D.
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the best model was selected based on the lowest DOPE
score. Next, for gave an idea about the quality of input
alignment the DOPE score profile (Figure 1) was calcu-
lated with “assess_dope” function of MODELLER. It can
be seen in Figure 1, that in the whole range of residues,
the DOPE score of both proteins converges and the re-
sults aren’t showing any problematic regions.
Analysis the trajectory of the molecular dynamics
simulation
During 5 ns MD simulation, the system was analyzed for
its stability. The deviation plot of potential, and root
mean square deviation (Figure 2) were derived from the
respective trajectory by Gromacs software output. The
low degree of RMSD fluctuation during last 2 ns indicatesFigure 4 Energy plot from ProSA program, all residues have
negative ProSA energies which confirms the reliability of
the model.that the system tends to be converging and therefore, it is
become stable. According to what illustrated in Figure 2,
the total energy of the complex was observed within the
range from −1.4 to −1.5 kJ/mol, which can be a reasonable
value.
Assess the validity of generated model after MD
In present work two statistical approaches such as veri-
fy3D and PROSA confirm a reliability of the constructed
model.
In the first approach, the Verify 3D profile (Figure 3)
represents that 3D-1D average score of the most resi-
dues in the model proteins both before and after MD,
given a score over 0.2 except the ones rage 514–532. In
the model protein that refined after MD, the whole resi-
dues have a positive score, whereas in the model that
constructed by the modeler the amino acids in the range
of 518–530 have a negative score. Therefore, based on
these results, the sign of model folding improvement
after molecular dynamic simulation is traceable.
The second statistical assessment method was processed
with ProSA program. The Normalized Z-score calculation
indicates standard deviation value is found in the range of
native conformation of crystallographic structure and also
according to Figure 4, ProSA score, which was calculated
interaction energy per residues, has a negative score across
the most of the residues’ length.
After performing those earlier methodologies based on
statistical approaches (Verify3D, ProSA), the PRoQ was
applied to compare the validity of the model before and
after MD simulation. This program is based on a neuralTable 1 Ramachandran plot statistics
% residues in most favored regions 90.8%
% residues in additional allowed regions 8.8%
% residues in generously allowed regions 0.4%
% residues in disallowed regions 0.0%
% Num. of non-glycine and non-proline residues 100.0%







Comparison values Comparison values No. of band
widths from meanTypical value Band width
%-tage residues in A,B,L 535 90.8 84.9 10.0 0.6 Inside
Omega angle Std. dev. 380 7.0 6.0 3.0 0.3 Inside
Bad contacts/100 residues 0 0.0 3.3 10.0 −0.3 Inside
Zeta angle Std. dev. 565 1.3 3.1 1.6 −1.1 Better
H-bond energy Std. dev. 400 0.7 0.8 0.2 0.5 Inside
Overall G-factor 581 0.0 −0.3 0.3 1.0 Better
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study it is indeed superior to statistics-based methods
[41]. In this method two quality measures are predicted,
LG score and MaxSub score. Based on their range of
qualities; predicted LG score and MaxSub score of the
model after MD is 4.14 (which is within the range of a
‘extremely good’) and 0.45( which are within the range
of ‘good’), while values of 2.915 and 0.304 were obtained
for LG score and MaxSub score, respectively in the
model before MD simulation. These scores indicate the
refinement of the model after MD simulation.
Ultimately, the validity of the model was evaluated by
PROCHECK, and stereochemical properties of protein
structure were listed in Tables 1 and 2 [31,42]. In the
Figure 5, phi and psi distribution of Ramachandran plot
indicate that 100% of residues were present in favored
and allowed regions, which confirm that the structure is
comparable with good homology model [43]. Also the
main chain parameters which consist of six properties
plotted are all well within the established limit of reliable
structures (Table 2).Figure 5 Ramachandran plot for 3D structural model of bovine
serum albumin.In brief, according to all applied evaluated methods, it
can be concluded that obtained 3.D structural model has
an acceptable geometry for further study by docking
approach.
Docking studies
With the interest of comparability of docking result with
experimental data (which studied the interaction among
flavonoids and BSA), and also shedding the light at an
ambiguous point of experimental observation in molecu-
lar level, with respect to Dufour and Dangles work [33]
one stage of docking simulation was designed. Therefore,
the binding interaction of quercetin (as the most studied
flavonoid) and warfarin (as a site marker of subdomain
IIA HSA) was subject to docking simulation.
First of all, in this process, the accuracy of applied
docking protocol was examined. So, warfarin as a probe
of HSA (whose high affinity binding site was known as a
subdomain IIA) was docked into HSA (PDB ID: 1H9Z),
which co-crystallized with it. Docking results demonstrates
that the warfarin docks back into the experimental binding
location which was retrieved based on the crystallographic
study (Figure 6).Therefore; this protocol was confirmed and
consequently, applied in docking simulation for complexes
of quercetin with HSA and BSA.Figure 6 The docking conformation and location of warfarin on
the Human serum albumin (PDB ID: 1H9Z). The conformation of
warfarin after docking indicates with DG colored sketch (David
Goodsell’s scheme) and what was retrieved from the crystallographic
study indicate as a blue sketch.
Figure 7 The structure of bovine serum albumin complexes with warfarin and quercetin (A, B), consequently (C) The structure of
human serum albumin complexes with warfarin and quercetin, (D) was analyzed using the Ligplot 4.22 program. The hydrogen bonds
are shown as dash lines and hydrophobic contacts are indicated with half-moon.
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participated amino acids in biding sites the Ligplot pro-
gram was employed [44]. It is indicated in Figure 7, That
in the binding site of bovine serum albumin, serine 284,
isoleucine 261 and 287, alanine 288 involve in hydropho-
bic interaction with quercetin and warfarin, and also
arginine 219 contribute in a hydrogen bond with both,Figure 8 The χ1/χ2 plots are obtained from PROCHECK program. Each
corresponding the range of yellow to red which is reflects the degree to w
in a favored and red indicate the residue is an unflavored region. Two tryp
plot indicate χ1/χ2 coordinate of tryptophans before MD (Left). The right pl
it is shown, trp 134 remains constant while the χ1/χ2 coordinates of trp 212this means that in the case of BSA, the warfarin and
quercetin binding sites completely overlap, while these
ligands are bonded in different location in HSA.
The Dufour and Dangles fluorescence spectroscopy study
had shown that fluorescence of BSA-quercetin complex
(protein/marker molar ratio of 1) is affected by constant
concentration of warfarin (site marker of subdomain IIA ),square represents one residue. The color coding of the squares is
hich the orientation is favored; therefore, yellow indicate the residue is
tophan of bovine serum albumin was indicated in both plots. The left
ot indicates the χ1/χ2 coordinates of tryptophans after MD (Right). How
is changed and located in unflavored region.
Johari et al. DARU Journal of Pharmaceutical Sciences 2014, 22:79 Page 8 of 12
http://www.darujps.com/content/22/1/79but fluorescence of HSA-quercetin complex is independent
of warfarin presence [33].
For better understanding of the relation between ex-
perimental observations and what was retrieved from
docking calculations. The more investigations were
taken to visualization the effect of BSA-flavonoids inter-
action on local conformational changes, which leads to
fluorescence quenching.Table 3 The free energy of binding between, 12 Flavones, 12
albumin obtained from docking study, and their AGEs inhibit
Num Name R1 R2 R3 R4 R5
1 Flavone H H H H H
2 7-Hydroxyflavone H H OH H H
3 Chrysin OH H OH H H
4 4,7-Dihydroxyflavone H H OH H H
5 3,4,7-Trihydroxyflavone H H OH H OH
6 Apigenin OH H OH H H
7 Luteolin OH H OH H OH
8 Diosmetin OH H OH H OH
9 Pilloin OH H OCH3 H OH
10 10 F OH H OCH3 H OC
11 Wogonin OH H OH OCH3 H
12 Baicalin OH OH OH H H
13 3-Hydroxyflavone H H H H H
14 Kaempferol OH H OH H H
15 Quercetin OH H OH H OH
16 Rhamnetin OH H OCH3 H OH
17 Tamarixetin OH H OH H OH
18 F18 OH H OCH3 H OH
19 Ombuine OH H OCH3 H OH
20 Ayanin OH H OCH3 H OH
21 21 F OH H OCH3 H OC
22 Myricetin H H H H H
23 Mearnsetin H H H H H
24 24 F H H CH3 H H
25 Liquiritigenin H H OH H H
26 26 F H H OCH3 H H
27 Eriodictyol OH H OH H OH
28 (+)-Catechin OH H OH H OH
29 (−)-Epigallocatechin OH H OH H OHFirst notable issue which was considered is that the
amino acids lining in the common binding site of quer-
cetin and warfarin, are neighbors of tryptophan 212
within 5Ǻ. This is important because the intrinsic fluores-
cence of BSA with excitation at 295 nm is due to the tryp-
tophan residues (BSA has two tryptophan, tryptophan 212
and tryptophan 134) and quercetin actually promoted a
strong quenching of the tryptophan emission at 340 nmFlavonols, 3 Flavanones, 2 Flavan-3-ols and bovine serum
ions’ IC50 (in regard to Matsuda, H., et al. [12])
R6 R7 R8 ΔG
(Kcal/mol)
AGEs inhibition IC50
(% in 200 μM)
H H H −7.09 5%
H H H −6.96 27%
H H H −7.56 43%
OH H H −7.0 44%
OH H H −7.53 44%
OH H H −7.52 53%
OH H H −7.53 64%
OCH3 H H −7.05 27%
OCH3 H H −7.9 29%
H3 OCH3 H H −7.0 29%
H H H −7.03 50%
H H H −7.75 79%
H H OH −7.1 3%
OH H OH −7.47 46%
OH H OH −7.67 57%
OH H OH −7.57 55%
OCH3 H OH −7.89 45%
OH H OCH3 −7.4 57%
OCH3 H OH −7.66 27%
OCH3 H OCH3 −7.66 40%
H3 OCH3 H OH −7.69 13%
H H OH −7.48 61%
CH3 H OH −7.51 10%
H H OH - 7.81 42%
OH H H −7.16 40%
OH H H −6.74 44%
OH H H −7.46 46%
OH H β-OH −7.74 69%
OH OH α-OH −7.06 4%
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the tryptophan flexibility after interaction between the
quercetin and BSA complex.
So, the complex of BSA model and quercetin (best
conformation after docking) was subjected to molecular
dynamic simulation for 2 ns. After the stability of the
system, for describing the side chain conformational
changes the dihedral angles of our interested aromatic
residue, χ1 / χ2 plot was provided by PROCHECK pro-
gram [31]. The results represent the significant shuffling
between side-chain conformations of tryptophan 212
before and after the refinement of BSA-quercetin complex
with molecular dynamic simulation. Figure 8 indicates
that the BSA residues which were involved in interaction
with quercetin, pushing the tryptophan 212 side chain
conformations to unflavored regions.
Discussion
In present work, based on docking calculation and molecu-
lar dynamic simulation, the detailed understanding was ob-
tained about the interaction of quercetin (as a typical
flavonoids) and BSA, which is in consistence with previous
experimental data [33]. In addition, these calculations in
molecular levels demonstrate its ability to providing the
interpretation for experimental observation.
The first-stage docking results confirm on one hand
the reliability of obtained 3D structural model, and on
the other hand, by showing the significant specificity be-
tween high homologous BSA and HSA proteins, indicate
the necessity of constructing BSA model’s for analyzing
the interaction flavonoids with it.
According to visualization of the predicted binding site
of quercetin, any interventions are not observed between
the quercetin binding site and reported glycation site of
BSA [18]. However, for the more reliable conclusion, a
number of flavonoids which introduced as an inhibitor
of BSA glycation [3,12] were employed for the further
docking studies.
By the speculation that the radical scavenging activ-
ity in physiological condition could inhibit oxidativeTable 4 The free energy of binding between 3 isoflavones an
and their AGEs inhibitions’ IC50
Num. Name R1 R2 R3 R4
30 Daidzein H H OH H
31 Genistein OH H OH H
32 Biochanin A OH H OH Hfragmentation of Amadori rearrangement product and
subsequently prevented the AGEs formation, the num-
ber of flavonoids was studied to find a correlation be-
tween the experimental anti glycation activity and
radical scavenging activity of them [12]. In the present
investigation with respect to their works, interested
flavonoids was selected and by considering an interfer-
ence reaction in the glycation site as the possible in-
hibitory mechanism [9,45,46], the theoretical binding
energies of flavonoids in the complex with BSA were
calculated by docking methods(calculated free energy
of binding were listed in Tables 3 and 4). Then, analytical
methods were performed by SPSS software (version 15).
The correlation analyzes between the experimental activ-
ity (IC50) and predicted binding energy reveal that there is
no significant correlation between these values (p > 0.3).
Besides the statistical analyzes, the AutoDockTools
(ADT) was used for visualization the relationship between
the predicted flavonoids’ binding site and the reported gly-
cation site on BSA. Interestingly, despite the structural
differentiations which exist among these flavonoids, the
most likely conformation of each one of them, were placed
in the same binding site (consist of lysine 219, arginine
215, isoleucine 287, and serine 284) (Figure 9) which can’t
be considered as any glycation sites of BSA (in respect to
aforementioned Hinton and Ames study). Therefore, by
considering these results, maybe it can be concluded that
the hydrophobic hindrances in the glycation site can’t be
considered as an inhibitory mechanism for flavonoids.
Conclusion
In previous experimental studies, the high homology
between BSA and HSA has invoked speculation that
they have a similar structure and so share similar cap-
ability in some of their properties like ligands binding
[45]. However, simulating the quercetin (as the most
studied flavonoids) interactions with both BSA and HSA
show significant differences between them, which confirms
our speculation about the necessity of providing the afford-
able BSA 3D structural model for analyzing its specificd bovine Serum albumin obtained from docking study,




Figure 10 The superimposition between crystallographic
structure of bovine serum albumin (PDB ID: 4F5S) (orange)
and calculated 3D structure model (yellow), obtained with
Swiss PDB viewer software.
Figure 9 The superimposition of docked complex. The most likely conformation of representative flavonoids of under study groups (Flavones,
flavonols, flavanones, flavan-3-ols, isoflavones), is represented in their binding site.
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ligands.
Interestingly, in the present study, the consistency be-
tween docking results and experimental data not only
indicate the validity of our simulation but also become
helpful in interpreting about experimental observation
in molecular levels [33].
Thus different aspect of results was considered, on one
hand the visualization of quercetin binding site leads to find
the relationship between the binding site residues and tryp-
tophan 212, and also by employing the MD simulation it is
revealed that participated residues in flavonoids interaction
site affect on tryptophan local conformational change,
which at last is observed as fluorescence quenching.
On the other hand, according to our obtained results,
the possibility of relation between the flavonoids binding
site and glycation sites was investigated, while the correl-
ation analyzes was adopted between binding affinity of
flavonoids to BSA and IC50 of AGE inhibition. How was
mentioned before based on the results, the flavonoids
can’t be considered as an intervention agent for glyca-
tion site and therefore, the possibility of this inhibitory
mechanism is unacceptable in the case of flavonoids.
Ultimately, the other interesting outcome of this study
is laid beneath the final examination. Coincident with
our study the crystallographic structure of bovine serum
albumin was determined [15]. Therefore, the compari-
son has been made between our calculated 3D structural
models of BSA with the reported model which retrievedfrom crystallographic technique to get insight into their
distinctive difference. These two structures were super-
imposed with Swiss PDB viewer software (Figure 10)
[47]. And strong correlation (RMSD: 1.9) between them
shades a light in the hypothesis that applied methods in
this study are accurate and reliable.
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